There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Specialty net revenue increased 19% to $115.64 million, driven by promoted products in neurology and endocrinology, including ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

These included 186,144 people with epilepsy, 169,127 with peripheral neuropathy (PN), 60,861 with Alzheimer’s or other ...

Critical Path Institute today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed as the new ...

Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.

Neurodegenerative diseases of aging like Parkinson's disease (PD) or Alzheimer's disease (AD) are usually not diagnosed until ...

Nilotinib, a drug approved by the US Food and Drug Administration ... and the International Parkinson and Movement Disorder ...

Blind, Randomized, Placebo-controlled, Study of Bezisterim in Subjects with Early Parkinson’s Disease is now fully funded. Favorable capital market conditions last week enabled the company to raise ...

Ventyx stock shows all the characteristics of a highly underappreciated issue with surprisingly valuable assets that can be ...